Laboratory News and Research

RSS

Using a vaccine to boost the response of engineered T cells

Engineering T cells to destroy cancer cells has shown success in treating some types of cancer, such as leukemia and lymphoma. However, it hasn't worked as well for solid tumors.

5 Jul 2023

Candidate genes for inflammatory bowel disease identified

A study of the genetic variation that makes mice more susceptible to bowel inflammation after a high-fat diet has identified candidate genes which may drive inflammatory bowel disease (IBD) in humans. The findings are published as a Reviewed Preprint in eLife.

5 Jul 2023

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella

A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice.

5 Jul 2023

Robotic system may accelerate studies in diverse areas of C. elegans biology

A robotic system capable of imaging and transferring the model organism Caenorhabditis elegans could replace hours of tedious lab work, according to a recent study.

5 Jul 2023

Arima Genomics continues momentum toward clinic with formation of clinical advisory board

Arima Genomics, Inc., a company leveraging 3D genomics to reveal actionable insights to improve human health and drive discovery in the life sciences, today announced the formation of a clinical advisory board to help the company advance its 3D genomics technologies into the clinical oncology and biopharmaceutical markets.

From Arima Genomics, Inc. 5 Jul 2023

Scientists identify blood proteins that may predict Type 1 diabetes

Scientists have taken an important step forward in predicting who will develop Type 1 diabetes months before symptoms appear.

4 Jul 2023

PSI-developed drug could increase survival chances for metastatic prostate cancer patients

Researchers at PSI have developed a new drug that could increase the survival chances of patients with metastatic prostate cancer.

4 Jul 2023

Unlocking the link: COVID-19 restrictions tied to surge in invasive Group A Streptococcal infections

Researchers investigated the increased incidence of group A streptococci (GAS) infections.

4 Jul 2023

Study sheds light on progress and gaps in hepatitis C clearance cascade

Researchers described the hepatitis C virus (HCV) elimination cascade during the direct-acting antivirals (DAA) era.

4 Jul 2023

Smoking and HPV found to increase risk of head and neck cancer

Tobacco smoking and human papillomavirus (HPV) are both well-known risk factors for head and neck cancer, but there is ample evidence to show they can interact to increase still further the risk of contracting the disease, according to a study by scientists at the University of São Paulo (USP) in Brazil and the University of Chile.

3 Jul 2023

New approach could improve accuracy of liquid biopsy tests

A research team led by Xianghong Jasmine Zhou, PhD, professor of Pathology and Laboratory Medicine at the David Geffen School of Medicine at UCLA, has made an important advancement to address one of the major challenges in cell-free DNA (cfDNA) testing, also known as liquid biopsy.

3 Jul 2023

Resistance training could be a simple and affordable therapy for Alzheimer's patients

Regular physical exercise, such as resistance training, can prevent Alzheimer's disease, or at least delay the appearance of symptoms, and serves as a simple and affordable therapy for Alzheimer's patients.

3 Jul 2023

Does COVID-19 increase the risk of bacterial infections in infants?

Researchers assess the prevalence of bacterial meningitis, bacteremia, and urinary tract infections among infants tested for viral infections.

3 Jul 2023

AI predicts on- and off-target activity of RNA-targeting CRISPRs

Artificial intelligence can predict on- and off-target activity of CRISPR tools that target RNA instead of DNA, according to new research published in Nature Biotechnology.

3 Jul 2023

Precision protection: antibody testing offers insights into predicting SARS-CoV-2 infection risk in immunocompromised patients

Researchers used antibody testing to predict the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection.

3 Jul 2023

Caffeine found to be most effective for treating birth asphyxia

Brain damage caused by oxygen deficiency at birth is one of the main causes of death in newborns worldwide. Using a small animal model, researchers from the University Hospital Bonn (UKB) and DZNE tested treatment with 25 different active agents.

3 Jul 2023

Covid deaths plummet in England, but dementia and heart disease remain a concern

New Government figures show a higher than average number of deaths last month. Dementia was the biggest killer in England and heart disease in Wales.

1 Jul 2023

OVUM highlights the potential of AI in revolutionizing IVF

The reproductive and fertility wellness brand, OVUM, highlights the potential of artificial intelligence (AI) in revolutionizing the In vitro fertilization (IVF) field.

1 Jul 2023

Intelligent neuro-orthosis could benefit patients with limited hand function

Patients with limited hand function are soon set to benefit from an intelligent neuro-orthosis that will enable them to lead independent lives again. Prof. Dr. Alessandro Del Vecchio, a neuroscientist at Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), is working on this aim in two new projects and has received over 1.3 million euros of funding from the Free State of Bavaria.

30 Jun 2023

Advances in influenza research

This interview with Dr. Mohammad S Safiarian, Associate Product Manager at Sino Biological, discusses the advances in influenza research and how effective vaccines are developed.

From Sino Biological Inc. 30 Jun 2023